Product Details
| Product Name: Umeclidinium bromide | CAS No.: 869113-09-7 |
| EC-No.: 638-761-1 | Min. Order: 1g |
| Purity: 99 | Supply Ability: 100KG |
| Release date: 2026/05/15 |
Umeclidinium bromide is a long-acting muscarinic acetylcholine antagonist developed by GlaxoSmithKline and approved by the US FDA at the end of 2013 for use in combination with vilanterol, a b2 agonist, for the treatment of chronic obstructive pulmonary disease. Due to umeclidinium’s poor oral bioavailability, the drug is administrated by inhalation as dry powder.
Company Profile Introduction
-
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
|
VIP5Y
|
Sinoway Industrial co., ltd.
|
2026-06-03 | ||
| $34.00 |
VIP6Y
|
TargetMol Chemicals Inc.
|
2026-06-02 | |
| $70.00 |
VIP3Y
|
Zibo Hangyu Biotechnology Development Co., Ltd
|
2026-05-05 | |
| $5.00 |
VIP3Y
|
Henan Fengda Chemical Co., Ltd
|
2025-09-25 | |
| $100.00 |
Hebei Yanxi Chemical Co., Ltd.
|
2025-06-20 | ||
| $10.00 |
Wuhan Xinhao Biotechnology Co., Ltd
|
2024-04-02 | ||
|
PNP Biotech Co. Ltd
|
2024-03-28 | |||
| $10.00 |
Anhui Zhongda Biotechnology Co., Ltd
|
2023-11-03 | ||
| $30.00 |
Wuhan wingroup Pharmaceutical Co., Ltd
|
2023-07-19 | ||
| $280.00 |
Hebei Mingeng Biotechnology Co., Ltd
|
2023-06-26 |
China- Since: 2018-09-06
- Address: B801, Jintai District, Baoji City, Shaanxi Province, China, Dongling Financial Plaza, Jintai Distric
INQUIRY
YANG
13892490616
gksales1@gk-bio.com
13892490616
gksales1@gk-bio.com